Pacira BioSciences Inc. (PCRX)
NASDAQ: PCRX
· Real-Time Price · USD
23.45
0.72 (3.17%)
At close: Oct 15, 2025, 3:59 PM
23.45
0.00%
After-hours: Oct 15, 2025, 04:10 PM EDT
Pacira BioSciences Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
Revenue | 700.97M | 674.98M | 666.82M | 541.53M |
Cost of Revenue | 170.43M | 184.67M | 199.29M | 140.25M |
Gross Profit | 530.54M | 490.31M | 467.53M | 401.28M |
Operating Income | -73.37M | 87.67M | 60.02M | 131.06M |
Interest Income | 19.69M | 11.44M | 4.54M | 896K |
Pretax Income | -63.11M | 61.7M | 13.3M | 56.4M |
Net Income | -99.56M | 41.95M | 15.91M | 41.98M |
Selling & General & Admin | 294.1M | 269.44M | 254.52M | 199.34M |
Research & Development | 81.58M | 76.26M | 84.8M | 55.55M |
Other Expenses | 228.23M | 56.94M | 57.29M | 13.55M |
Operating Expenses | 603.91M | 402.63M | 396.6M | 268.44M |
Interest Expense | 16.57M | 20.31M | 39.98M | 31.75M |
Selling & Marketing Expenses | 172.01M | 153.04M | 145M | 111.02M |
Cost & Expenses | 774.34M | 587.3M | 595.9M | 408.7M |
Income Tax Expense | 36.45M | 19.75M | -2.61M | 14.42M |
Shares Outstanding (Basic) | 46.24M | 46.22M | 45.52M | 44.26M |
Shares Outstanding (Diluted) | 46.24M | 51.98M | 46.54M | 45.63M |
EPS (Basic) | -2.15 | 0.91 | 0.35 | 0.95 |
EPS (Diluted) | -2.15 | 0.81 | 0.34 | 0.92 |
EBITDA | 29.12M | 157.58M | 144.78M | 118.47M |
EBIT | -49.67M | 79.01M | 48.88M | 85.4M |
Depreciation & Amortization | 78.78M | 75.57M | 91.5M | 28.55M |
Source: Financial Modeling Prep. Financial Sources.